Decisions about protecting your company’s IP can’t wait — founders must start aligning their IP and company strategies as soon as possible, even during the formation of the company itself.
Featured Article
2021 should be a banner year for biotech startups that make smart choices early
The median step up in biotech valuations from seed to Series A is now 2x, higher than in all later rounds. As a result, biotech startups will continue to attract more investment at earlier stages.
12:12 pm PDT • April 23, 2021
